| Structure | Chemical Name | CAS | MF |
|
N1-(p-Chlorobenzoyl)-N1,N2-bis(p-nitrophenyl)formamidine
|
|
C20H13ClN4O5
|
|
N-[1-(p-Chlorobenzyl)-4-piperidyl]-2-pyrimidinamine
|
|
C16H19ClN4
|
|
N1-(p-Chlorobenzoyl)-N1,N2-diphenylformamidine
|
|
C20H15ClN2O
|
|
N2-[2-(p-Chloro-N-methylanilino)ethyl]benzamidine
|
|
C16H18ClN3
|
|
N-[4-[(p-Chlorobenzyl)oxy]phenyl]-3,4,5,6-tetrahydrophthalamidic acid
|
|
C22H21ClN2O5
|
|
N-(p-Chlorophenyl)-N-(p-methoxyphenyl)acetamide
|
|
C15H14ClNO2
|
|
N1-(p-Chlorophenyl)-N1-(p-chlorobenzoyl)-N2-(p-nitrophenyl)acetamidine
|
|
C21H15Cl2N3O3
|
|
2-[N'-(p-Chlorophenyl)hydrazino]-4-methoxy-2,4-dimethylvaleronitrile
|
|
C14H20ClN3O
|
|
N-(p-Chloro-α-phenylbenzyl)-N'-(2,6-xylyl)-1,2-ethanediamine
|
|
|
|
N'-[α-(p-Chlorophenyl)benzyl]-N,N-diethylethylenediamine
|
23921-02-0
|
C19H25ClN2
|
|
N-(P-CHLOROPHENYL)-4-CYCLOHEXENE-1,2-DICARBOXIMIDE
|
43069-64-3
|
C14H12ClNO2
|
|
N-(P-CHLOROPHENYL)URETHANE
|
2621-80-9
|
C9H10ClNO2
|
|
N-(P-CHLOROBENZYL)-PYRIDINIUM CHLORIDE + N-(P-CHLOROBENZYL)-PICOLINIUM CHLORIDE
|
|
C25H24Cl4N2
|
|
N-(P-CHLORO-ALPHA,ALPHA-DIMETHYL PHENETHYL)UREA
|
15240-59-2
|
C11H15ClN2O
|
|
N-((p-Chlorophenyl)amidino)-1-piperidinecarboxamidine hydrochloride
|
19803-79-3
|
|
|
N-((p-Chlorophenyl)amidino)-4-morpholinecarboxamidine hydrochloride
|
19803-81-7
|
|
|
N-(P-CHLOROBENZOYL)-GAMMA-(P-ANISIDINO) BUTYRIC ACID
|
|
C18H18ClNO4
|
|
4-[N-(P-Chloro-Benzoyl)-N-(P-Methoxyphenyl)]Aminobutyric Acid
|
|
C18H18ClNO4
|
|
N-((p-Chlorophenyl)amidino)-4-methyl-1-piperidinecarboxamidine monohyd rochloride
|
19803-80-6
|
|
|
N-P-CHLOROPHENYL-DIAMIDOPHOSPHORIC ACID)
|
25316-34-1
|
C6H8ClN2O2P
|
|
N-P-CHLOROBENZOYL-P-METHOXYPHENYL HYDRAZINE
|
|
C14H13ClN2O2
|
|
N-(P-Chloro-Benzoyl)Tyramine
|
|
C15H14ClNO2
|
|
N-(P-CHLOROPHENYL)-P-TOLUENESULFONAMIDE
|
|
C13H12ClNO2S
|
|
N-(P-CHLOROPHENYL)-4,5-DIHYDRO-3-FURAMIDE
|
|
C11H10ClNO2
|
|
N-(3-(P-CHLOROPHENOXY)-2-HYDROXYPROPYL)PHTHALIMIDE
|
|
C17H14ClNO4
|
|
2-(N-(P-CHLOROPHENYL)ACETAMIDO)-N,N-DIMETHYLACETAMIDE
|
|
C12H15ClN2O2
|
|
N-(P-CHLOROPHENYL)-N-TOSYLACETAMIDE
|
|
C15H14ClNO3S
|
|
N-(3-(P-CHLOROPHENOXY)-2-HYDROXYPROPYL)SUCCINIMIDE
|
|
C13H14ClNO4
|
|
N-(P-CHLOROPHENYL)-4-METHYL-8-NITRO-2-QUINOLINAMINE
|
|
C16H12ClN3O2
|
|
N-(p-chlorophenyl)-2-cyano-2-[2,3-dihydro-3-[tetrahydro-2,4,6-trioxo-1-p-tolylpyrimidin-5(2H)-ylidene]-1H-isoindol-1-ylidene]acetamide
|
85959-60-0
|
C28H18ClN5O4
|
|
|
N-[β-(p-Chlorobenzoyloxy)phenethyl]-N,N-diethyl-2-ethoxy-2-oxoethanaminium
|
|
|
|
|
N-(p-Chloro-α-phenylbenzyl)-N,N',N'-trimethyl-1,2-ethanediamine
|
|
|
|
N-(p-Chlorobenzoyl)-N-(2,6-xylyl)norleucine
|
|
C21H24ClNO3
|
|
N'-(p-Chlorophenyl)-N-[p-[2-(diisopropylamino)ethoxy]phenyl]benzamidine
|
31118-17-9
|
C27H32ClN3O
|
|
N-(p-Chlorophenyl)carbamodithioic acid ethyl ester
|
709-88-6
|
C9H10ClNS2
|
|
N1-(p-Chlorophenylthio)-N1-methyl-N2-(2,4-xylyl)formamidine
|
55311-62-1
|
C16H17ClN2S
|
|
N-(p-Chlorobenzyl)nonanamide
|
|
C16H24ClNO
|
|
N-(p-Chlorobenzylidene)-p-iodoaniline
|
71511-62-1
|
C13H9ClIN
|
|
N-[[4-(p-Chlorobenzyl)-1-piperazinyl]methyl]phthalimide
|
|
C20H20ClN3O2
|
|
1-[N-[4-[(p-Chlorophenyl)sulfonyl]phenyl]amidino]guanidine
|
|
C14H14ClN5O2S
|
|
N-[2-(p-Chlorophenyloxy)-2-methylpropyl]acetamide
|
|
C12H16ClNO2
|
|
N-(p-Chlorophenyl)carbamodithioic acid benzyl ester
|
730-12-1
|
|
|
N-[α-(p-Chlorophenyl)benzyl]-N'-(1-propenyl)ethylenediamine
|
63918-47-8
|
C18H21ClN2
|
|
N1-(p-Chlorophenyl)-N1-tosyl-N2-(p-methylphenyl)acetamidine
|
|
C22H21ClN2O2S
|
|
α-[N-(p-Chlorobenzyl)amino]-o-hydroxybenzylphosphonic acid hydrogen butyl ester
|
105660-02-4
|
|
|
N1-(p-Chlorobenzoyl)-N1,N2-bis(p-chlorophenyl)acetamidine
|
|
C21H15Cl3N2O
|
|
N1-(p-Chlorophenyl)-N1-(p-methylphenyl)-N2-[(p-nitrophenyl)sulfonyl]acetamidine
|
|
C21H18ClN3O4S
|
|
N-(p-Chlorobenzylidene)methylamine
|
|
C8H8ClN
|
|
N1-(p-Chlorobenzoyl)-N1,N2-diphenylacetamidine
|
|
C21H17ClN2O
|
|
N-(p-Chlorophenyl)isonicotinamidine
|
23565-10-8
|
C12H10ClN3
|
|
N1-(p-Chlorophenyl)-N1-tosyl-N2-(p-nitrophenyl)acetamidine
|
|
C21H18ClN3O4S
|
|
4-[1-[N-(p-Chlorophenyl)carbamoyl]-2-oxopropylazo]-3-nitrobenzenesulfonic acid sodium salt
|
|
C16H12ClN4NaO7S
|
|
N-[2-(p-Chlorophenyloxy)-1,2-dimethylpropyl]acetamide
|
|
C13H18ClNO2
|
|
N-[α-(p-Chlorophenyl)benzyl]-N'-cyclohexylethylenediamine
|
23892-45-7
|
C21H27ClN2
|
|
|
N-(p-Chloro-α-phenylbenzyl)-N'-propyl-1,2-ethanediamine
|
|
|
|
N-(p-Chlorobenzoyl)-N-(2,6-xylyl)-β-alanine
|
30544-73-1
|
C18H18ClNO3
|
|
|
N-(p-Chloro-α-phenylbenzyl)-N-methyl-N'-propyl-1,2-ethanediamine
|
|
|
|
N-[[4-(p-Chlorobenzyl)-1-piperazinyl]methyl]succinimide
|
|
C16H20ClN3O2
|
|
N'-(p-Bromophenyl)acetohydrazide
|
|
C8H9BrN2O
|
|
N'-(p-Bromobenzoyl)acetohydrazide
|
74038-71-4
|
C9H9BrN2O2
|
|
N-(p-Bromophenyl)carbamic acid 4-thiocyanato-2-butynyl ester
|
14223-12-2
|
C12H9BrN2O2S
|
|
N'-(p-Bromophenyl)benzhydrazide
|
|
C13H11BrN2O
|
|
N-[4-(p-Bromophenyl)-3-phenyl-1,2,4-thiadiazol-5(4H)-ylidene]benzamide
|
33863-65-9
|
|
|
|
N-(p-Bromophenyl)-α-propyl-α-hydroxybenzeneacetamide
|
|
|
|
N-(p-Bromobenzyl)-N-(6-methyl-4-pyrimidinyl)-N',N'-dimethylethylenediamine
|
|
C16H21BrN4
|
|
N-(p-Bromophenyl)-N,N'-dimethyl-N'-phenylethylenediamine
|
32857-44-6
|
|
|
1-[N-[4-(p-Bromophenyl)sulfonylphenyl]amidino]guanidine
|
|
C14H14BrN5O2S
|
|
N-(p-Bromophenyl)ethanehydrazonoyl chloride
|
74305-91-2
|
C8H8BrClN2
|
|
N-(P-BROMOPHENYL)-N-METHYLACETAMIDE
|
|
C9H10BrNO
|
|
NOMIFENSINE
|
89664-20-0
|
C16H18N2
|
|
NOMIFENSINE MALEATE
|
24526-64-5
|
C16H18N2
|
|
NOMIFENSINE MALEATE SALT
|
32795-47-4
|
C16H18N2.C4H4O4
|
|
|
NolR protein
|
144715-57-1
|
|
|
|
NOMIFENSSINE
|
|
|
|
NOMILINICACID17-BETA-D-GLUCOPYRANOSIDE
|
141304-78-1
|
C34H48O16
|
|
nomilin glucoside
|
338957-99-6
|
C34H46O15
|
|
Nomilen
|
84128-96-1
|
C30H51Ca2Cl2MgN4NaO26P+5
|
|
Nomilin
|
1063-77-0
|
C28H34O9
|
|
NOMILIN17-BETA-D-GLUCOPYRANOSIDE
|
141304-77-0
|
C34H46O15
|
|
N-[2-(P-CINNAMYLAMINO)ETHYL]-5-ISOQUINOLONE SULFONAMIDE
|
130964-40-8
|
C20H21N3O2S
|
|
|
nominal phosphoprotein, rabies virus
|
|
|
|
|
NOMINAL FREEZING POINT (-50 )
|
|
|
|
|
NOMINAL FREEZING POINT (-45 )
|
|
|
|
nonaammonium heptahydrogen [2,5,8,11,14,17-hexakis(phosphonatomethyl)-2,5,8,11,14,17-hexaazaoctadecane-1,18-diyl]bisphosphonate
|
93858-91-4
|
C54H156N27O72P24-27
|
|
nonaammonium pentahydrogen [[(phosphonatomethyl)imino]bis[ethylene[(phosphonatomethyl)imino]ethylenenitrilobis(methylene)]]tetrakisphosphonate
|
93892-76-3
|
C15H47N6O21P7
|
|
nonaammonium hydrogen [[(phosphonatomethyl)imino]bis[ethane-2,1-diylnitrilobis(methylene)]]tetrakisphosphonate
|
93919-74-5
|
C63H216N36O243P8136*-63
|
|
nonaammonium trishydrogen [ethane-1,2-diylbis[[(phosphonatomethyl)imino]ethane-2,1-diylnitrilobis(methylene)]]tetrakisphosphonate
|
94023-10-6
|
C30H126N21O90P3012*-9
|
|
3,5,7-NONAATRIEN-2-ONE
|
|
C9H12O
|
|
2,2,3,3,4,5,5,6,6-NONABROMODIPHENYL ETHER
|
437701-78-5
|
C12HBr9O
|
|
|
2,2',3,3',4,4',5,5',6- NonaBDE
|
|
|
|
[1,2,3,9,10,16,17,23,24-nonabromo-11,25-dichloro-29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]copper
|
68425-85-4
|
C32H5Br9Cl2CuN8
|
|
2,2',3,3',4,4',5,5',6-NONABROMOBIPHENYL
|
69278-62-2
|
C12HBr9
|
|
|
2,2',3,3',4,4',5,6,6'-Nonabromodiphenylether,10 ug/mL in isooctane
|
|
|
|
Nonabine
|
16985-03-8
|
C25H33NO2
|
|
|
non-Abeta component of AD amyloid protein
|
|
|
|
|
Non-absorbefacient paper printing ink
|
|
|
|
2,2',3,3',4,4',5,5',6-nonabromodiphenylether
|
63387-28-0
|
C12HBr9O
|
|
2,2',3,3',4,4',5,6,6'-nonabde
|
437701-79-6
|
C12HBr9O
|
|
nonabromo-1,1'-biphenyl
|
27753-52-2
|
C12HBr9
|
|
2,2',3,3',4,4',5,6,6'-NONABDE
|
|
C12HBr9O
|